Baillie Gifford
Baillie Gifford is an independently owned firm that focuses on investment and asset management.
Business Model:
Revenue: $1B
Employees: 1,001-5,000
Rankings
Industries / Tags:
Detailed Baillie Gifford Information
Geographic Data
Address: Calton Square, 1 Greenside Row
City: Edinburgh
State: scotland
Zip: EH1 3AN
Country: GB
Financial Info
Stage:
Raised Last:
$0
Raised Total:$720M
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
297,568Website Global Rank
203,626Website Monthly Traffic
Twitter Followers
Description
Baillie Gifford is an independently owned investment management firm. It is owned and run by 39 of its senior executives who operate as a partnership, a structure which has endured for over a century and which provides stability for clients and motivation for employees. It enables them to manage the business for the future as well as the present, with the emphasis on genuine long–term thinking rather than lurching haplessly between short term targets. Baillie Gifford is unique in the UK in being a large-scale investment business that has remained an independent private partnership. This ownership structure has allowed them to keep their efforts focused entirely on their clients and their investments.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2018 | Slack | Series H | 427M |
| 4/2018 | Manbang Group | Private Equity Round | 0 |
| 9/2020 | Zymergen | Series D | 300M |
| 3/2022 | Blockchain.com | Series D | - |
| 11/2021 | Aker Horizons | Post-IPO Equity | 116.6M |
| 9/2020 | Gojo &a; Company | Series D | 0 |
| 6/2022 | Echodyne | Series D | 0 |
| 8/2021 | Joby Aviation | Post-IPO Equity | 0 |
| 11/2021 | Faire | Series G | 0 |
| 4/2015 | Funding Circle | Series E | 150M |
| 10/2016 | UNITY Biotechnology | Series B | 116M |
| 3/2018 | UNITY Biotechnology | Series C | 55M |
| 8/2017 | UNITY Biotechnology | Series B | 35M |
| 11/2021 | Aurora | Post-IPO Equity | 0 |
| 8/2020 | Epic Games | Equity | 1.5B |
| 11/2020 | Manbang Group | Private Equity Round | 1.7B |
| 10/2019 | Workrise | Series D | 0 |
| 9/2016 | Intarcia Therapeutics | Series E | 0 |
| 12/2021 | Pet Circle | Series C | 0 |
| 7/2021 | Rappi | Series F | 500M |
| 1/2021 | Lyra Health | Series E | 187M |
| 11/2019 | Convoy | Series D | 400M |
| 10/2020 | Honor | Series D | 140M |
| 11/2017 | HeartFlow | Series E | 0 |
| 8/2021 | Blockstream | Series B | 210M |
| 5/2021 | Delhivery | Series H | 277M |
| 6/2020 | Lilium | Venture Round | 35M |
| 4/2023 | HeartFlow | Series F | 0 |
| 3/2016 | Home24 | Venture Round | 22.8M |
| 6/2022 | Echodyne | Series C | 0 |
| 6/2019 | Carbon | Series E | 0 |
| 6/2021 | SHINE Medical Technologies | Series C | 150M |
| 7/2022 | Merlin Labs | Series B | 0 |
| 5/2019 | Tempus | Series F | 0 |
| 8/2018 | Tempus | Series E | 110M |
| 4/2021 | Epic Games | Equity | 1B |
| 9/2020 | Allbirds | Series E | 0 |
| 1/2020 | Allbirds | Series D | 25M |
| 7/2019 | FlixBus | Series F | 563.1M |
| 11/2020 | Nuro | Series C | 500M |
| 9/2020 | Affirm | Series G | 500M |
| 12/2020 | Tempus | Series G | 200M |
| 11/2017 | Wise | Series E | 280M |
| 6/2021 | sennder | Series D | 80M |
| 3/2017 | Moneytree | Series B | 9M |
| 11/2021 | Nuro | Series D | 0 |
| 8/2021 | VerSe Innovation | Series I | 451M |
| 1/2016 | Meituan | Venture Round | 3.3B |
| 10/2022 | Recursion Pharmaceuticals | Post-IPO Equity | 150M |
| 7/2019 | Thumbtack | Series F | 150M |
| 8/2015 | Zocdoc | Series D | 130M |
| 12/2017 | Carbon | Series D | 0 |
| 4/2020 | Warby Parker | Series F | 125M |
| 12/2016 | HelloFresh | Series G | 88.3M |
| 5/2021 | sennder | Series D | - |
| 1/2022 | McMakler | Venture Round | 0 |
| 3/2019 | Zipline | Series D | 120M |
| 5/2017 | AUTO1 Group | Series E | 402.4M |
| 4/2022 | Convoy | Series E | 0 |
| 4/2022 | Indiabulls Real Estate | Post-IPO Equity | 0 |
| 11/2015 | Ola | Series F | 500M |
| 12/2014 | Momentive | Private Equity Round | 250M |
| 12/2020 | Zomato | Series J | 660M |
| 2/2016 | Souq | Venture Round | 275M |
| 3/2021 | Loft | Series D | 0 |
| 4/2022 | UPSIDE Foods | Series C | 0 |
| 11/2017 | NIO | Series D | 1.1B |
| 6/2020 | Oscar Health | Private Equity Round | 225M |
| 3/2021 | Stripe | Series H | 600M |
| 3/2020 | Tempus | Series G | 0 |
| 9/2015 | Thumbtack | Series E | 125M |
| 10/2021 | Brex | Series D | 300M |
| 6/2021 | Thumbtack | Series I | 275M |
| 9/2021 | Spiber Inc. | Private Equity Round | 0 |
| 4/2022 | VerSe Innovation | Series J | 0 |
| 3/2021 | Gopuff | Series G | 0 |
| 12/2014 | Flipkart | Series H | 700M |
| 3/2023 | Stripe | Series I | 6.5B |
| 12/2017 | Lyft | Series H | 0 |
| 3/2022 | PropertyGuru | Post-IPO Equity | 0 |
| 10/2019 | Scopely | Series D | 400M |
| 3/2022 | BillionToOne | Series C | 0 |
| 1/2020 | Joby Aviation | Series C | 0 |
| 12/2020 | Oscar Health | Pre-IPO | 140M |
| 10/2022 | Solugen | Series D | 0 |
| 9/2015 | HelloFresh | Series F | 85.6M |
| 4/2022 | Climeworks | Private Equity Round | 0 |
| 6/2021 | Relativity Space | Series E | 0 |
| 4/2020 | Cohesity | Series E | 250M |
| 12/2017 | Orchard Therapeutics | Series B | 0 |
| 6/2016 | Ginkgo Bioworks | Series C | 0 |
| 9/2020 | Recursion Pharmaceuticals | Series D | 239M |
| 8/2018 | Orchard Therapeutics | Series C | 0 |
| 4/2020 | PsiQuantum | Series C | 150M |
| 5/2018 | Akili Interactive Labs | Series C | 0 |
| 5/2021 | Akili Interactive Labs | Series D | 0 |
| 6/2020 | Sana Biotechnology | Series A | 700M |
| 11/2015 | Udacity | Series D | 105M |
| 8/2016 | Denali Therapeutics | Series B | 130M |
| 4/2020 | Zomato | Series J | 5M |
| 10/2018 | NIO | Post-IPO Equity | - |
| 5/2016 | Wise | Series D | 26M |
| 5/2019 | Wise | Secondary Market | 292M |
| 3/2021 | Blockchain | Series C | 0 |
| 1/2016 | Skyscanner | Venture Round | 192M |
| 7/2022 | Northvolt | Convertible Note | 0 |
| 5/2019 | Away | Series D | 100M |
| 6/2021 | Zipline | Series E | 250M |
| 3/2018 | Zipline | Series C | 70M |
| 9/2020 | Jiangxiaobai | Venture Round | 300M |
| 6/2015 | Home24 | Venture Round | 131.1M |
| 7/2021 | PsiQuantum | Series D | 450M |
| 9/2018 | Indigo | Series E | 250M |
| 9/2017 | Indigo | Series D | 203M |
| 9/2021 | Solugen | Series C | 0 |
| 5/2021 | Workrise | Series E | 0 |
| 1/2022 | DNA Script | Series C | 0 |
| 12/2020 | Graphcore | Series E | 0 |
| 2/2020 | Graphcore | Series D | 150M |
| 10/2020 | Tanium | Private Equity Round | 150M |
| 10/2018 | Tanium | Private Equity Round | 200M |
| 4/2021 | Astranis | Series C | 250M |
| 12/2018 | SpaceX | Series J | 486.2M |
| 8/2020 | Warby Parker | Series G | 120M |
| 4/2021 | Capsule | Series D | 300M |
| 5/2021 | MasterClass | Series F | 0 |
| 11/2015 | CureVac | Series F | 0 |
| 10/2021 | Honor | Series E | 70M |
| 3/2021 | ChargePoint | Post-IPO Equity | 225M |
| 1/2016 | Flatiron Health | Series C | 175M |
| 4/2022 | Lightning Labs | Series B | 0 |
| 9/2020 | Northvolt | Series B | 0 |
| 11/2017 | Uptake Technologies | Series D | 117M |
| 8/2021 | Databricks | Series H | 0 |
| 7/2020 | Wise | Secondary Market | 319M |
| 6/2021 | FlixBus | Series G | 0 |
| 1/2021 | Horizon Robotics | Series C | 0 |
| 1/2022 | Wayve | Series B | 0 |
| 9/2018 | KSQ Therapeutics | Series C | 80M |
| 12/2022 | BillionToOne | Series C | 0 |
| 8/2021 | Databricks | Series H | 1.6B |
| 6/2021 | Northvolt | Venture Round | 0 |
| 11/2017 | Bolt Threads | Series D | 123M |
| 7/2021 | Redwood Materials | Series C | 700M |
| 1/2017 | Funding Circle | Series F | 100M |
| 9/2021 | Discord | Series H | 500M |
| 9/2021 | Snyk | Series F | 304M |
| 11/2021 | Grammarly | Private Equity Round | 200M |
| 7/2022 | Merlin Labs | Series B | 0 |
| 7/2022 | Northvolt | Convertible Note | 0 |
| 6/2022 | Echodyne | Series D | 0 |
| 4/2022 | Convoy | Series E | 0 |
| 4/2022 | UPSIDE Foods | Series C | 0 |
| 4/2022 | Indiabulls Real Estate | Post-IPO Equity | 0 |
| 4/2022 | VerSe Innovation | Series J | 0 |
| 4/2022 | Climeworks | Private Equity Round | 0 |
| 4/2022 | Lightning Labs | Series B | 0 |
| 3/2022 | BillionToOne | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
